Please ensure Javascript is enabled for purposes of website accessibility

No. 5: Kenneth Frazier (access required)

Health Care Power 50

In February, Kenilworth-based Merck said it would spin off products from its women’s health, trusted legacy brands and biosimilars businesses into a new – yet-to-be-named – independent, publicly traded company. It was the latest move by Frazier as president and CEO to refocus the giant drugmaker.

Write to the Editorial Department at